Showing results (261-270 of 347) with videos related to

Sort By:
Pageof 35
Frontiers in Pharmacology|September 23, 2024
Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance studyJingying Wu, Jianru Wu, Biyu Tang, et al.
Cell Reports|May 17, 2024
Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responsesBin Qian, Rui Lu, Shuya Mao, et al.
Veterinary Microbiology|July 2, 2020
Humoral immune responses in piglets experimentally infected with a field strain of porcine epidemic diarrhea virusHaiyong Guo, Zuojun Yao, Ligong Chen, et al.
BMC Public Health|November 26, 2025
Elderly abuse and depressive symptoms among older adults: loneliness and social participation as mediators and moderatorsYisong Yao, Yuemei Xiao, Yumei Li, et al.
BMC Cancer|June 1, 2019
Validity and reliability of the EQ-5D-5 L in family caregivers of leukemia patientsLimin Li, Chaojie Liu, Xiuzhi Cai, et al.
Life Sciences|October 6, 2024
AP-2α decreases TMZ resistance of recurrent GBM by downregulating MGMT expression and improving DNA damageGuixiang Huang, Mi Ouyang, Kai Xiao, et al.
Health and Quality of Life Outcomes|March 24, 2017
Factors associated with the quality of life of family caregivers for leukemia patients in ChinaHongjuan Yu, Limin Li, Chaojie Liu, et al.
Journal of Colloid and Interface Science|March 17, 2025
Co-assembly of antimicrobial polypeptoids/carbon dots for internal-external cooperated sterilizationShang Wang, Chao Huang, Yiyu Gong, et al.
Oncotargets and Therapy|October 24, 2018
Low-dose hypomethylating agent decitabine in combination with aclacinomycin and cytarabine achieves a better outcome than standard FLAG chemotherapy in refractory/relapsed acute myeloid leukemia patients with poor-risk cytogenetics and mutationsLimin Li, Xiaoqian Zhang, Hongjuan Yu, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Possible Association Between Concomitant Use of SSRIs with NSAIDs and an Increased Risk of Adverse Events Among People with Depressive Disorders: Data Mining of FDA Adverse Event Reporting SystemYi Zhang, Xiaoyu Liu, Jianru Wu, et al.
Pageof 35